|
| Issue Date | Title | Author(s) |
| 2023 | Aneugenic and clastogenic alterations in the DBA/IJ mouse model of rheumatoid arthritis treated with rituximab, an anti-CD20 antibody | Al-Hamamah, Mohammed A; Alotaibi, Moureq R; Alasmari, Abdullah F; Attia, Mohamed SM; Ahmad, Sheikh F; Mahmoud, Mohamed A; Nadeem, Ahmed; Ansari, Mushtaq A; Bakheet, Saleh A; Moustafa, Mohamed said attia |
| 2019 | Genetic and epigenetic alterations induced by the small-molecule panobinostat: A mechanistic study at the chromosome and gene levels | Al-Hamamah, Mohammed A; Alotaibi, Moureq R; Ahmad, Sheikh F; Ansari, Mushtaq A; Nadeem, Ahmed; Bakheet, Saleh A; Sobeai, Homood M As; Attia, Sabry M; Moustafa, Mohamed said attia |
| 2022 | Treatment with the anti-CD20 monoclonal antibody rituximab mitigates gonadal disruptions in the collagen-induced arthritis in male DBA/1 J mouse model | Al-Hamamah, Mohammed A; Alotaibi, Moureq R; Ahmad, Sheikh F; Nadeem, Ahmed; Ansari, Mushtaq A; Bakheet, Saleh A; Alanazi, Mohammed M; Moustafa, Mohamed said attia |
| 2020 | Vorinostat is genotoxic and epigenotoxic in the mouse bone marrow cells at the human equivalent doses | Attia, Sabry M; Al-Khalifa, Mohamed K; Al-Hamamah, Mohammed A; Alotaibi, Moureq R; Attia, Mohamed SM; Ahmad, Sheikh F; Ansari, Mushtaq A; Nadeem, Ahmed; Bakheet, Saleh A; Moustafa, Mohamed said attia |
